Bnp Paribas Arbitrage Sa Has Trimmed Zebra Technologies (ZBRA) Position; Shorts at GEOVAX LABS (GOVX) Lowered By 84.76%

June 14, 2018 - By Darrin Black

Zebra Technologies Corporation (NASDAQ:ZBRA) Logo

Bnp Paribas Arbitrage Sa decreased Zebra Technologies Corp (ZBRA) stake by 40.78% reported in 2018Q1 SEC filing. Bnp Paribas Arbitrage Sa sold 9,872 shares as Zebra Technologies Corp (ZBRA)’s stock rose 9.90%. The Bnp Paribas Arbitrage Sa holds 14,338 shares with $2.00 billion value, down from 24,210 last quarter. Zebra Technologies Corp now has $8.44B valuation. The stock increased 0.03% or $0.04 during the last trading session, reaching $158.06. About 170,014 shares traded. Zebra Technologies Corporation (NASDAQ:ZBRA) has risen 45.77% since June 14, 2017 and is uptrending. It has outperformed by 33.20% the S&P500. Some Historical ZBRA News: ; 23/05/2018 – CORRECTING and REPLACING Zebra Medical Vision Announces CE Approval of its Seventh AI Imaging Algorithm – Mammography Lesion; 18/04/2018 – Mobile Heartbeat Achieves Zebra Technologies Validation; 08/05/2018 – ZEBRA TECH 1Q ADJ EPS $2.56, EST. $2.05; 08/05/2018 – Zebra Sees 2Q Adj EPS $2.10-Adj EPS $2.30; 15/05/2018 – lnsomniac, LiveXLive, Zebra Entertainment And Tencent Video Sign Partnership Agreement To Distribute Livestream Of Electric Daisy Carnival (EDC) Las Vegas; 05/03/2018 – Zebra Medical Vision Announces CE Approval of Its Newest Al Imaging Algorithm – Automatic Identification of Brain Bleeds; 24/05/2018 – Zebra Tech Presenting at AllianceBernstein Conference May 31; 24/04/2018 – ZEBRA HOLDINGS AND INVESTMENTS S.à.R.L. ACQUIRES UNITS OF GENERATION MINING LIMITED; 21/04/2018 – DJ Zebra Technologies Corporation Clas, Inst Holders, 1Q 2018 (ZBRA); 08/05/2018 – Zebra 1Q Net $109M

GEOVAX LABS INC (OTCMKTS:GOVX) had a decrease of 84.76% in short interest. GOVX’s SI was 24,400 shares in June as released by FINRA. Its down 84.76% from 160,100 shares previously. The SI to GEOVAX LABS INC’s float is 0.04%. It closed at $0.0388 lastly. It is down 0.00% since June 14, 2017 and is . It has underperformed by 12.57% the S&P500.

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines against infectious diseases and cancer using its novel vaccine platform in the United States. The company has market cap of $5.89 million. It is developing various vaccines that are in human clinical trials, and preclinical research and development phases, including vaccines against human immunodeficiency virus ; Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. It currently has negative earnings. The firm has collaboration and partnership agreements with National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the HIV Vaccines Trial Network, Centers for Disease Control and Prevention, United States Army Research Institute of Infectious Disease, Emory University, University of Georgia Research Foundation, University of Pittsburgh, Georgia State University Research Foundation, Peking University, University of Texas Medical Branch, Burnet Institute, American Gene Technologies, Inc., Viamune, Inc., The Scripps Research Institute, and Institute of Human Virology.

Bnp Paribas Arbitrage Sa increased Altice Usa Inc stake by 92,500 shares to 102,500 valued at $1.89B in 2018Q1. It also upped Burlington Stores Inc (NYSE:BURL) stake by 39,823 shares and now owns 61,166 shares. Cme Group Inc/Il (NASDAQ:CME) was raised too.

Among 12 analysts covering Zebra Tech (NASDAQ:ZBRA), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. Zebra Tech had 31 analyst reports since August 12, 2015 according to SRatingsIntel. Northcoast upgraded the shares of ZBRA in report on Tuesday, October 31 to “Buy” rating. The firm has “Outperform” rating by Imperial Capital given on Wednesday, November 29. The stock of Zebra Technologies Corporation (NASDAQ:ZBRA) earned “Buy” rating by Wellington Shields on Wednesday, November 8. The firm has “Outperform” rating given on Friday, May 13 by Barrington Research. The firm earned “Equal-Weight” rating on Wednesday, May 31 by Morgan Stanley. The stock of Zebra Technologies Corporation (NASDAQ:ZBRA) has “In-Line” rating given on Monday, February 27 by Imperial Capital. The rating was maintained by Morgan Stanley with “Equal-Weight” on Friday, February 23. Barrington maintained the stock with “Buy” rating in Tuesday, August 15 report. The firm has “Overweight” rating by JP Morgan given on Monday, March 26. The stock of Zebra Technologies Corporation (NASDAQ:ZBRA) earned “Buy” rating by Robert W. Baird on Thursday, October 5.

Analysts await Zebra Technologies Corporation (NASDAQ:ZBRA) to report earnings on August, 14. They expect $1.92 EPS, up 38.13% or $0.53 from last year’s $1.39 per share. ZBRA’s profit will be $102.52 million for 20.58 P/E if the $1.92 EPS becomes a reality. After $2.36 actual EPS reported by Zebra Technologies Corporation for the previous quarter, Wall Street now forecasts -18.64% negative EPS growth.

Since February 26, 2018, it had 0 insider purchases, and 14 insider sales for $17.20 million activity. TERZICH MICHAEL H also sold $446,418 worth of Zebra Technologies Corporation (NASDAQ:ZBRA) shares. On Wednesday, February 28 GAGNIER HUGH K sold $1.33M worth of Zebra Technologies Corporation (NASDAQ:ZBRA) or 9,560 shares. GUSTAFSSON ANDERS sold $3.12M worth of stock or 20,459 shares. 2,024 shares were sold by Cho Michael, worth $314,084. The insider KAPUT JIM L sold 4,884 shares worth $709,352. Schmitz Jeffrey F sold 1,474 shares worth $208,556. 2,000 shares were sold by MANIRE ROSS W, worth $270,340.

Investors sentiment decreased to 1.09 in 2018 Q1. Its down 0.15, from 1.24 in 2017Q4. It fall, as 28 investors sold ZBRA shares while 106 reduced holdings. 70 funds opened positions while 76 raised stakes. 46.29 million shares or 0.51% less from 46.52 million shares in 2017Q4 were reported. American Mgmt has invested 1.25% in Zebra Technologies Corporation (NASDAQ:ZBRA). 67 were reported by Qs Investors Limited Liability Corp. Oregon Employees Retirement Fund reported 20,099 shares stake. State Street invested 0.02% of its portfolio in Zebra Technologies Corporation (NASDAQ:ZBRA). State Of Alaska Department Of Revenue reported 0.01% in Zebra Technologies Corporation (NASDAQ:ZBRA). Arizona State Retirement System has invested 0.05% in Zebra Technologies Corporation (NASDAQ:ZBRA). Barclays Public Limited Co accumulated 22,743 shares. 417,457 were accumulated by Northern Trust. Moreover, Natixis Advsrs LP has 0.06% invested in Zebra Technologies Corporation (NASDAQ:ZBRA) for 44,666 shares. Parametric Associates Limited Liability Corp owns 93,495 shares. Voloridge Mngmt Ltd stated it has 0.1% in Zebra Technologies Corporation (NASDAQ:ZBRA). Tci Wealth Advisors Inc invested in 163 shares. Los Angeles Capital Mgmt Equity Incorporated holds 0.03% of its portfolio in Zebra Technologies Corporation (NASDAQ:ZBRA) for 32,566 shares. Nordea Inv Management invested in 22,960 shares. Dekabank Deutsche Girozentrale owns 1,300 shares for 0% of their portfolio.

Zebra Technologies Corporation (NASDAQ:ZBRA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News